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1. Introduction 
Focal liver lesions (FLL) are common pathological findings in patients investigated for 
different gastrointestinal and other diseases. After detecting FLL radiologically, their clinical 
differential diagnosis is very important. 
The precise identity and description of blood circulation of FLL is essential for differential 
diagnosis by computer tomography (CT). This is why the evaluation of the effectiveness of 
CT diagnostic criteria in diagnosing FLL is a relevant problem of theoretical and practical 
radiology, gastroenterology, surgery and oncology. 
Multislice spiral CT is a perfect imaging modality to evaluate large area in a short time and 
visualize lesion optimally with an injection of contrast media (c/m). Scanning may include 
unenhanced images (without c/m), arterial, portal venous and delayed phases. The speed of 
contrast  injection and optimal scanning protocol are crucial to separate all phases, what is 
very important in differential diagnostics of FLL. 
It is important to optimize scanning time delay in order to achieve qualitative liver CT 
images. This can be achieved in few ways, including fixed time delay, “bolus” test and 
automatic scanning technology. In most hospitals and clinics contrast enhanced CT is 
performed simultaneously with the same scan delay . 
To evaluate focal liver lesions Foley and Mallisee suggested triphasic multislice CT. When 
the whole liver is scanned in 10 sec. or even less, it’s possible to achieve different liver CT 
images in particular time. In arterial phase (25-30 sec. after c/m injection) you can see the 
ramification of arteries without portal blood addition, contrary in portal veinous phase c/m 
flows into portal vein. This phase is in 45-50 sec. after the c/m injection starts. 
In daily practice additional venous phase images are not necessary, however it could help in 
doubtful cases. This phase starts in about 70-120 sec. after IV “bolus” injection. As 
concentration of non-ionic c/m, including iodine, inside and outside the artery is probably 
the same, some FLL have tendency to “disappear” in this phase. Despite that, this phase is 
very useful in differentiating cholangiocarcinoma (I-CCC) from other FLL. Delayed phase is 
important in differential diagnosis of  cholangiocarcinoma and hemangioma. 
Murakami et al. described double CT scanning in arterial phase. Analyzing early and 
delayed arterial phase CT images, the so called pseudo-tumours can be found that is a great 
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problem for the patients with liver cirrhosis. But the importance of this method is 
controversial nowadays, so it is not included into the CT scanning protocols. 
In contrast enhanced CT, faster injection (4-5 ml/sec.) is recommended, which guarantees 
earlier and brighter peak of enhancement in the arteries, and also improves temporal 
separation of arterial, portal veinous and venous phases. 
Concentration of c/m is also very important in contrast enhanced CT. Data from few 
sources confirms the hypothesis that the concentration of c/m improves greater  
enhancement and hypervascular liver lesions diagnostics. 
Multislice spiral CT has a few advantages in abdominal imaging: gradual and minor 
inspiration and breath hold decrease body movements and ensure higher quality of the 
images. With improvement of CT scanners optimization of scanning is necessary to 
maximize the ability of getting new CT images. 
Few studies suggest that multiple-phase CT scans are useful in differentiation and blood 
supply evaluation of solitary liver lesions. This is why CT scans should be evaluated 
separately in all phases. 
There are multiple FLL types. Even such condition as fatty liver degeneration which is not 
considered as tumour should be differentiated. This is the reason why all FLL must be 
classified to make their diagnosis as objective and precise as possible. 
Based on the literature, incidentally found <2.0 cm liver lesions of unknown origin, are 
benign in 75% of all cases, but USA scientists say, it is only about 50%. Scientists from Italy 
state that <1.5 cm FLL, diagnosed in people with extra-hepatic malignant process are benign 
in 80% of all cases. 
From radiological point of view FLL are classified to hyper- and hypovascular, and also 
cystic and solid. 
The aim is to describe the most important contrast enhanced CT diagnostic criteria for 
differentiating solid FLL. 
2. Most common benign focal liver lesions 
Liver cysts are the most common FLL, and they are usually detected incidentally during 
common follow-up. Liver cysts have specific US, CT and MRI features, so the radiological 
diagnosis is always clear, usually not complicated and it is not a medicine practice problem. 
This is why the diagnostics of liver cysts is not discussed in this paper. The diagnostics of 
non-cystic lesions is much more important and topical. 
2.1 Liver hemangioma  
Liver hemanioma is the most common (after liver cysts) benign liver lesion presenting 0.4-
20% of all liver tumours. Normally it is solitary, well-defined vascularized lesion that can 
reach 20.0 cm in size. Hemangioma is composed of multiple vascular channels surrounded 
by endothelium cells with thin fibrotic stroma. Large hemangiomas are usually detected in 
older patients, with an average age of 54 years. Giant hemangiomas have non-homogenous 
structure because of fibrosis, necrosis, and cystic zones. 
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On unenhanced CT scans hemangiomas are hypodense with well-defined boarders. 
Calcification is rare (10-20%) and usually detected occasionally. Calcifications have rarely 
been reported in sclerosed or hyalinized and giant hemangiomas. The calcifications can be 
marginal or central; large and coarse; or multiple, small, and punctuate (e.g. phleboliths). 
Massive calcification of hemangiomas is extremely rare. The finding of a non-enhancing 
liver tumour with calcification should not preclude the diagnosis of hemangioma.  
Performing contrast enhanced CT (in 2-15 min. after the injection of contrast media) 
peripheric nodular enhancement with centripetal fill in is observed. An early enhancement 
of FLL even before contrast media appears in the aorta is typical for hemangioma. 
According to several authors, globular enhancement in hemangiomas is seen with 88% of 
sensibility and 84-100% specificity. The lesion is filled-in with c/m depending on the size of 
hemangioma (fig.1). 
    
                                      (a)                                                                              (b) 
   
                                     (c)                                                                          (d) 
Fig. 1. Typical hemangioma. (a) Precontrast axial CT images demonstrate a hypodense 
lesion in the right hepatic lobe. (black arrow) (b,c) Arterial-phase and venous-phase images 
show progressive, peripheral nodular enhancement of the lesion with centripetal fill in. 
(arrow) (d) Delayed-phase images show that the lesion is isodense compared to the 
surrounding liver parenchyma an appearance that suggest persistence of contrast material 
within the lesion. (arrow)   
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Small hemangiomas (42% of hemangiomas are <1 cm) enhance rapidly and intensively in an 
early arterial phase (about 16% of all hemangiomas). The smaller the lesion, the faster it fills 
in with c/m. 
This sign makes it more difficult to differentiate hemangiomas from other hypervascular 
tumours: islet cell metastases, small HCC, etc. Small hypodense hemangiomas are 
particularly problematic in patients with underlying malignancy. Some metastases can also 
have peripheral globular enhancement. Leslie et al. noticed that up to 8% of all cases 
metastases can show the same enhancement pattern. Another important differential 
diagnostic sign of hemangioma is attenuation equivalent to that of the aorta during all CT 
phases. Another valuable sign in differential diagnosis of hemangioma and malignant liver 
lesion is peripheric hypodense rim at the periphery of the mass. It indicates malignant 
neoplasm and is never seen in hemangiomas.  
Large hemangiomas usually look like heterogenic lesions that enhance normally, however large 
hemangiomas with scar tissue do not enhance gradually, thus, there are non-enhanced areas. 
In the late phase (10 min. after injection of contrast media) hemangiomas become isodense 
to surrounding liver parenchyma. This is one of the most important signs in differential 
diagnostics of hemangioma (fig.2) 
  
                                     (a)                                                                             (b) 
Fig. 2. Atypical hemangioma. (a) Portal venous- phase; there is no visible enhancement in 
the lesion (b) Delayed-phase CT image shows that the lesion is isodense compared to the 
liver (circle).  
Sometimes in the late phase slight peripheral enhancement may be seen. This way of 
contrast uptake is typical of hialinized hemangioma that, according to some authors, is the 
last stage of the development of hemangioma. These hemangiomas must be differentiated 
from malignant tumours of the liver. Percutaneous biopsy is indicated in these cases. In the 
late phase small hemangiomas (<1 cm) are still slightly hypodense, but hypervascular 
metastases become contrast-free. 
In case of liver steatosis hemangiomas are usually iso- or hyperdense. On unenhanced CT 
images hemangiomas are isodense to hepatic vessels. Thrombosed, fibrosed or 
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degenerated areas are specific to large hemangiomas and are hypodense compared to 
hepatic vessels. 
Though centripetal fill in is specific to hemangiomas, this finding is not pathognomic; 
sometimes hepatocellular carcinoma (HCC), cholangiocarcinoma or even liver metastases 
may have the same features. What is more, early peripheral nodular enhancement can be 
found in some focal nodular hyperplasia or vascular abnormalities. 
Liver hemangiomas are differentiated from focal nodular hyperplasia (FNH) in up to 23% of 
all cases, however two or more different lesions may be found in the same liver. 33% of 
multiple FNH should be differentiated with hemangioma. When the tumours have typical 
CT features, the diagnosis can be made with confidence. 
Large heterogeneous hemangiomas must be differentiated from all liver lesions that have 
scars: FNH, hepatocellular adenoma (HCA), hepatocellular carcinoma (HCC), intrahepatic 
cholangiocarcinoma. Large hemangiomas usually demonstrate cleft-like central or eccentric 
areas of scarring that constitute areas of fibrosis, sclerosis (i. e. hyalinization), cystic 
degeneration, or thrombosis. These areas have variable shape and size and usually do not 
demonstrate delayed contrast enhancement (fig.3). 
  
                                          (a)                                                                       (b) 
  
(c) 
Fig. 3. Large hemangioma. Contrast-enhanced CT images show the typical enhancement 
pattern of hemangioma. 
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The essential criteria of evaluation of liver hemangiomas CT images are as follows: 
hypodense or isodense lesion on precontrast CT images;early peripheral nodular ring 
enhancement in arterial phase with centripetal fill-in in portal venous phase; and isodense 
lesion in the delayed phase. Based on these criteria our study shows that CT scanning is 91 
% sensitive and 93 % specific. 
2.2 Focal nodular hyperplasia 
Focal nodular hyperplasia (FNH) is the hyperplasic process of liver, characterized by 
normal histological view of liver structure, but abnormal arrangement of it. FNH accounts 
for 1-8% of all primary liver tumours and it is the second most common benign liver 
neoplasm (after hemangiomas). FNH is diagnosed mostly in women (80-90%) in their 
twenties-fifties. Oral contraceptives are very important for the development of FNH, 
particularly the growth of it, but not formation de novo. In men FNH can be diagnosed in 
those taking anabolic steroids or having testicular tumour. 
  
                                       (a)                                                                       (b) 
  
(c) 
Fig. 4. Focal nodular hyperplasia with deformation of the liver margin . (a) In the arterial 
phase the hypervascular lesion with a hypodense central scar appears. (b,c) In the portal 
venous phase CT image FNH is iso- or hypodense to the liver. (arrow) 
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Etiology and pathogenesis of FNH are unclear. Histologically it is characterized as neoplasm 
with star-shaped central scar, surrounded with nodules of hyperplastic liver cells and minor  
ile ducts. In 95% of cases FNH is well-defined solid tumour with clear margins and central 
scar with blood vessels coming from it. Normally FNH is less than 5.0 cm in diameter and 
they are usually diagnosed not smaller than 3.0 cm. 
On non-enhanced CT images FNH appears as hypodense (42-57%) or isodense (40-48%) 
lesion without well-defined borders and sometimes with more intensive hypodense central 
zone. If the lesion is isodense, the ‘mass’ effect may be the only criteria for detecting FNH. In 
15-33% of patients, unenhanced CT images show the hypoattenuating stellate central scar 
with a central core and radiating fibrous septa. FNH is often subcapsular and that can 
complicate the course of adjacent vessels. 
One third of FNH grows exophyticly and deforms contours of the liver (fig.4). 
In arterial phase FNH enhances rapidly and becomes hyperdense (89-100%) because of 
vascularization of hepatic arteries (entering the FLL). In this situation hypodense central 
scar is seen clearly . 
In portal venous phase the difference between FNH and normal liver parenchyma 
decreases, and later lesion becomes hypodense except for the central scar which is 
hyperdense in this phase (usually this scar is formed of efferent central vein) (fig.5). 
  
                                             (a)                                                                          (b) 
Fig. 5. Focal nodular hyperplasia. (a) Arterial phase CT image shows homogeneous 
enhancement of the lesion, except for the central scar. (arrow) (b) Contrast-enhanced CT 
image on the portal venous phase shows isoattenuating enhancement of the lesion 
compared to the liver. (arrow). 
Although the typical CT features of FNH are characteristic, atypical features may be seen in 
more than half of cases. Multiple focal nodular hyperplasias occur in about 20% of patients. 
Atypical FNH may show less intense enhancement, unusual appearance on non-enhanced 
central scar and pseudocapsular enhancement on delayed images. In these cases it is very 
difficult to differentiate FNH from other benign and malignant lesions, such as HCA, HCC, 
hypervascular liver metastases of FLC. 
A central scar is histologically present in almost all patients with FNH. However, it may be 
subtle and extremely small and is identified with the use of CT in 30%–50% of cases. 
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Presence of a central scar is clearly related to the size of the lesion. 35% of small FNH (<3 
cm) and 65% of large FNH (>3 cm) demonstrated central scar. FNH lesions smaller than 3 
cm in size may be more difficult to distinguish from other hypervascular lesions. The scar is 
typically thin and small and is hypodense compared with the rest of the FNH on 
unenhanced images, hepatic arterial and portal venous phase images. On delayed phase 
images, the scar often becomes hyperdense because of retention of contrast media (fig.6). 
   
                                           (a)                                                                      (b) 
 
(c) 
Fig. 6. Large atypical focal nodular hyperplasia. (a) Arterial phase CT image shows 
lobulated enhancement with a thick irregular scar of the lesion. (b,c) In the portal venous 
phase, FNH is slighthy hypodense to the liver. The central scar shows contrast 
enhancement. Pseudocapsule is evident.  
Although central scar is very specific for FNH, it can also be seen in other atypical malignant 
liver lesions, such as gigantic liver hemangioma. 
Pseudocapsule is one of atypical FNH signs (8% of cases), which is usually seen in liver 
steatosis because of the peripheral fibrosis of liver under pressure. Pseudocapsule may be 
more dense than the liver or FNH. Pseudocapsule should not be regarded as a sign of 
malignancy. 
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Internal haemorrhage or necrosis is seen in less than 6% of all cases. Calcification, fatty or 
necrotic zones are not common findings in FHN. 
In some patients with hepatic steatosis, FNH is still isodense or hypodense on non-enhanced 
CT images; in rare cases, this may be due to fatty infiltration of FNH. Hypothetically, 
intralesional steatosis in focal nodular hyperplasia can be expected in several types of 
hepatic injury associated with steatosis, such as alcoholic toxicity, obesity, diabetes, 
malnutrition, and protein malabsorption.  
FNH-like nodules in the cirrhotic liver are usually hypervascular, and they can mimic HCC. 
Although CT images give you precise diagnosis of FNH in most cases, rarely, a false-
positive diagnosis of FNH occurs in cases of fibrolamellar hepatocellular carcinoma, as well 
as in cases involving other well-differentiated variants of hepatocellular carcinoma. The 
essential FNH criteria of evalution are as follows: slightly hypodense lesion with brighter 
low density zone in the centre on unenhanced CT images; strongly homogenous 
enhancement with hypodense central zone in the arterial phase; and isodense zone with 
central hyperdense zone in the venous phase. CT scanning is 78% sensitive and 89% specific. 
2.3 Hepatocellular adenoma 
Hepatocellular adenoma (HCA) is a rare benign liver lesion, which in 80% of cases is a 
solitary well defined tumour with a capsule. Oral contraceptives and steroids are one of 
the reasons of HCA development. HCA are more common in women in their twenties-
forties. The difficulty of differential diagnosis of FNH and HCA is further compounded 
by the fact that both types of lesion typically occur in fertile women with a history of oral 
contraceptive use, who may be asymptomatic. People with glycogen metabolism 
disorders and haemosiderosis, as well as anabolic steroids taking males, are at a greater 
risk of HCA development. By the way pregnancy is one of the HCA risk factors. Normally 
HCA are 8-10 cm sized; in 70-80% of cases they are solitary tumours, however multiple 
adenomas can occur (sometimes >10 cm). HCA are difficult to differentiate from other 
hypervascular liver tumours. 
Adenomas are more likely to contain areas of heterogenicity, fat, necrosis, hemorrhage and 
calcification rather than FNH. Adenomas are well defined (85% of cases), non-lobulated 
(95%), sometimes encapsulated (30%) and rarely calcified (10%). 
While adenomas are also benign, they have a low-grade-malignancy potential, may bleed 
spontaneously, and are usually resected if they are large or if the diagnosis is doubtful. The 
diagnosis of this benign tumour is important as there is a possibility of rupture.  
Approximately 50% of tumours demonstrate intratumoural haemorrhage and can present 
with haemoperitoneum followed by hypotension and shock. 
HCA can transform into hepatocellular carcinoma. 
Adenomas consist almost entirely of uniform hepatocytes and a variable number of Kupffer 
cells, most of the adenomas in our experience are nearly isodense compared to normal liver 
on unenhanced images, portal venous, and delayed-phase images. 
Diagnosis of HCA based only on CT scans is complicated, although a few specific HCA 
signs can be described. On precontrast CT images fatty HCA inserts may look like 
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hypodense areas, and acute subcapsular haemorrhage looks like hyperdense areas. Necrosis 
and haemorrhage are detected in nearly 25% of HCA. 
On contrast enhanced CT images in arterial phase you can see intensive peripheral contrast 
enhancement, which is caused by subcapsular vessels of the lesion. Central part of the lesion is 
filled with contrast media (cm) pretty fast as well. The lesion becomes hyperdense, however 
we can see washout and in portal-venous and late phases HCA becomes isodense. HCA 
showed more wash-out in the portal phase and 22% of the HCA may be hypodense (fig. 7). 
  
                                         (a)                                                                        (b) 
 
(c) 
Fig. 7. CT images of large hepatocellular adenoma. A big lesion is seen in S6, deformes 
hepatic inferior border and goes down up to the level of the right kidney (a) Coronal image. 
(b,c) Axial images.  Hepatic CT arterial phase (a,b) shows slightly heterogeneous 
enhancement of the tumor. (c) Portal venous CT phase: tumor becomes isointense and 
homogenous. 
These features are typical to the lesions that are smaller than 3.0 cm in size. In some cases a 
thin capsule can be identified. Small adenomas enhance faster than normal liver tissue. In 
about 80% of cases HCA demonstrated homogeneous or nearly homogeneous enhancement, 
except for the acute or previous haemorrhage or fatty tissue in it. 
In patients with liver steatosis HCA is hyperdense in all phases. 
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The differentiation of adenoma from hypervascular metastases may be difficult or even 
impossible. Most hypervascular metastases are multiple and will manifest as lesions or 
portions of lesions that are hypoattenuating or hypodense compared to normal liver 
parenchyma on unenhanced images, portal venous, and late-phases. It is crucial to identify 
if there is a primary tumour, for example, pancreatic or kidney carcinoma. In the age group 
of women, who are usually diagnosed with HCA, breast or thyroid carcinomas are the most 
likely to be the primary tumours. 
The essential HCA diagnostic criteria are as follows: isodense lesion on unenhanced CT 
images; diffuse homogenous enhancement in arterial phase; isodense lesion in venous 
phase. Contrast enhanced CT shows 71% sensitivity and 93% specificity. 
2.4 Rare benign focal liver lesions 
2.4.1 Angiomyolipoma  
Aniomyolipoma is a benign mesenchymal tumour that usually involves the kidney and rarely 
the liver. Lipomas or angiomyolipomas have been found in 10% of patients with tuberous 
sclerosis but can occur in patients without the disease. Angiomyolipomas can be diagnosed in 
patients of different age and sex, but are more common in women. The lesion can be of different 
size and may be solitary or multiple. Extremely rare cases of hepatic angiomyolipomas with 
spontaneous rupture, tumor recurrence, and vascular invasion were reported. 
Hepatic angiomyolipomas are composed of varying portions of fat, epithelioid and spindled 
smooth muscle cells, and thick-walled blood vessels. The imaging features of hepatic 
angiomyolipomas depend on the relative proportions of the tumour components. It is 
difficult to diagnose hepatic AMLs with low fat content. Occasionally, it is difficult to 
distinguish hepatic AMLs from other fat-containing hepatic tumours, such as HCC with 
fatty metamorphosis, lipoma, and liposarcoma. The feeding blood vessels can be seen in 
other hypervascular lesions such as HCC and FNH, but the vessels in those cases usually are 
located in the periphery of the lesion.  
  
                                         (a)                                                                       (b) 
Fig. 8. Angiomyolipoma in S2 of the liver. (a) Nonenhanced CT scan shows a hypoattenuating  
fat-containing lesion in the left liver lobe. (arrow) (b) Arterial phase CT image shows slightly 
heterogeneous hyperenhancement in the vascular area of the lesion. (arrow)   
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On contrast enhanced CT images, hepatic angiomyolipomas strongly enhance in the arterial 
phase and enhancement persists in the venous phase, depending on the vascularisation of 
the tumour. Such hepatic angiomyolipomas should be differentiated from HCCs and 
cavernous hemangiomas (fig. 8). 
2.4.2 Liver hamartoma  
Liver hamartoma is a benign mesenchymal cystic tumour, consisting of gelatinous 
mesenchymal tissue with cyst formation and remnants of normal hepatic parenchyma. The 
tumour may have either mesenchymal predominance (a solid appearance) or cystic 
predominance (multiloculated cystic masses). On CT images mesenchymal hamartoma is a 
well defined lesion with hypodense central part and septa. Both solid and cystic areas are 
seen (fig.9). 
  
                                          (a)                                                                         (b) 
Fig. 9. Mesenchymal hamartoma of the liver. (a) unenhanced CT images: we see cystic 
lesions in S7 (b)  enhancement of the septa in portal venous phase. (arrow) 
2.4.3 Liver TB granuloma 
Liver TB granuloma is the most common manifestation of upper abdominal 
parenchymatous organ tuberculosis and its incidence has also been increasing. There are 
three morphological types of liver TB: miliary tuberculosis of the liver associated with 
generalized miliary tuberculosis, primary miliary tuberculosis of the liver and primary 
tuberculoma or abscess of the liver. More than half of the patients present with 
hepatomegaly. 
Radiological findings of hepatic tuberculosis are not specific. On CT images liver 
tuberculoma appears as an unenhancing, central, low density lesion due to cessation 
necrosis with a slightly enhancing peripheral rim corresponding to surrounding 
granulation tissue. Calcification can also be observed. TB granuloma should be 
differentiated from necrotic tumours, such as metastatic carcinoma and hepatocellular 
carcinoma (fig. 10). 
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Fig. 10. Liver tuberculosis. Contrast enhanced CT image shows a large irregular miliary 
confluent calcification. The liver is dicreased in size with irregular margins.   
3. Most common malignant focal lesions 
Malignant liver tumours are one of the most common oncological diseases all over the 
world. 
It is still unknown why some of the liver cells become malignant; however it is well-known 
that people with differently damaged liver are at a greater risk of developing liver cancer. 
The highest risk of liver damage is for those infected with hepatitis B and C viruses. These 
and other diseases can cause liver cirrhosis, which induces scarring of liver tissue. When the 
tumour develops in cirrhotic liver, patient’s survival and recovery rates are tragically low; 
and the only treatment option in this situation is liver transplantation. 
Malignant liver tumours are more common in men than women (2.7:1) (based on USA data). 
According to American Cancer Association (ACA) in 2007 liver tumours were diagnosed de 
novo in 13650 males and 5510 females. 
ACA says liver tumours are among 20 most common oncological diseases in the USA. 
Though World Health Organization (WHO) states that liver cancer is the third most 
common mortality reason.  
In Japan since 1995 the incidence of liver tumours has also been rising, and mortality from 
liver tumours is up to 30/100000. About 30000 Japanese people die from liver cancer 
annually . 
In some African and Eastern Asian countries liver cancer is the most common type of 
malignancy. 
According to Lithuanian Cancer Registration Department the rate of liver cancer was 
132/100000 in 2001 and 162/100000 in 2005. Primary data on liver cancer in 2010 shows 
general morbidity of 142/100000: among them 94/100000 – males, 48/100000 – females. 
In 2005 liver cancer caused 174/100000 deaths, 89/100000 of them – males and 85/100000 – 
females. 
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3.1 Hepatocellular carcinoma  
Hepatocellular carcinoma (HCC) is the most common malignant liver lesion caused by 
hepatocytes damage. Very often HCC is diagnosed in patients who already have some 
underlying liver disease, such as chronic viral hepatitis, alcoholic cirrhosis, 
haemochromatosis, etc. With growing population of people with hepatitis C and the 
disease’s tendency to become chronic or cause liver cirrhosis, there is no doubt hepatitis C 
will become the most important HCC risk factor. 
HCC is more common in males than females (4:1) in their fifties-seventies. In some African 
and Asian countries HCC rate reaches its maximum at 40 yrs.  
When the fibrosis is concentrated focally, a finding, often referred to as a focal confluent 
fibrosis, can create mass lesions that simulate tumours on cross sectional images. These 
lesions often radiate from the porta hepatis and are wedge-shaped and widest at the 
capsular surface. The most common sites for confluent fibrosis are the anterior and medial 
segments of the liver, but it can be present anywhere else. The reliable finding in 
differentiation of confluent fibrosis from HCC is associated atrophy of hepatic parenchyma 
with capsular retraction (fig.11). 
  
                                           (a)                                                                        (b) 
Fig. 11. Liver fibrosis. (a) Arterial phase CT image shows heterogeneous area in the right 
liver lobe, liver capsule retraction. (b) The portal venous phase CT image shows a 
hyperenhancement of the fibrotic area. Dilated bile ducts in the left liver lobe. 
HCC can be solitary, multifocal or diffusely infiltrating, what is least common. Multifocal 
HCC may look like multiple small foci or one dominant large tumour with multiple satellite 
nodules. HCC classification can also be based on its growth characteristics. Highly 
differentiated tumour grows slowly, meanwhile tumour with low grade of differentiation 
demonstrate aggressive growth patterns. 
HCC has a tendency to spread locally involving portal (30-60%) and other hepatic veins 
(15%). Portal vein is usually involved when the tumour is infiltrative. Intravenously 
growing tumour must be differentiated from thrombi, based on HCC arterial or venous 
signal depending on recanalization.  
Serum AFP levels are often elevated in patients with large tumours, and the serum AFP 
level is frequently normal in patients with small tumours. 
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CT is highly accurate in the staging of HCC, as the number of lesions, segmental anatomy, 
regional adenopathy, vascular tumour invasion and metastases can be detected easily. 
On unenhanced CT images HCC looks like a hypodense lesion. It often happens that small 
HCCs are not detected on precontrast CT. In HCC, however, there may be metamorphosis, 
necrosis, periodic changes or haemorrhage; therefore, it is usually heterogeneous attenuation, 
especially in large HCCs. Fatty metamorphism usually occurs in high grade differentiated 
HCC and on unenhanced images it looks as a hypodense lesion. In some instances, increased 
attenuation within the HCC may be due to haemorrhage or calcifications. 
Focal hyperdense fragments (calcification areas) or diffuse hyperdense changes (iron 
accumulations) inside the neoplasm are extremely rare (5-10%). 
Optimal liver CT scanning protocol is based on accumulation of contrast substance in 
arterial, portal vein and venous phases during spiral CT. 
  
                                            (a)                                                                      (b) 
 
(c) 
Fig. 12. Hepatocellular carcinoma. (a) Arterial phase CT image shows a typical 
hyperenhancement of the lesion. (arrow) (b,c) HCC shows washout in portal venous phase. 
Pathologic diagnosis of this tumor was moderately differentiated hepatocellular carcinoma. 
(arrow)  
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The most common HCC sign in arterial phase is enhancement or persistent enhancement 
and wash-out in portal veinous and venous phases on CT or MRI (fig.12). 
Intensive enhancement in HCC is caused by a good vascularization of the tumour. In early 
arterial phase, the lesions enhance homogeneously or heterogeneously, while most of the small 
HCC lesions enhance homogeneously. Areas of internal necrosis or fat may remain hypodense. 
In the portal venous and equilibrium phases, the contrast media is moving from the 
intravascular to the intercellular space. The wash-out is rapid because HCC contains less 
intercellular space than the surrounding liver parenchyma. 
The imaging characteristics of HCC vary greatly with the size of the lesion. 
Diffusely infiltrating HCCs may be difficult to detect on CT during any enhancement phase 
(fig.13). 
  
                                            (a)                                                                       (b) 
  
                                           (c)                                                                         (d) 
Fig. 13. Diffusely infiltrating hepatocellular carcinoma. (a) Hepatic arterial phase CT image 
shows slighly heterogeneous mass in the right lobe of the liver and hyperattenuating 
enhancement of the hepatic parenchyma. (b,c) In the portal venous phase and delayed phase 
CT images, the tumor shows washout. 
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Pathologic diagnosis of the tumor was diffusely infiltrating hepatocellular carcinoma. 
Well-differentiated and small HCCs more often had atypical enhancement features.  
Small HCC (<3 cm) can be hypovascular, do not enhance intensively or show no enhancement 
at all in arterial phase. In 10% of all cases enhancement is not intensive due to high 
differentiation degree of HCC. In this situation HCC is easier to identify in portal veinous and 
venous phases, when hypodense HCC foci are seen due to contrast wash-out (fig. 14). 
  
                                         (a)                                                                         (b) 
 
(c) 
Fig. 14. Atypical hepatocellular carcinoma. (a,b) Arterial and portal venous phase show an 
atypical finding with no enhancement in the lesion. (arrow) (c) Delayed phase image shows 
no visible enhancement of the tumor. (arrow) 
If HCC is big (> 5 cm), it is identified as a heterogeneous tumour in arterial phase. In these 
cases additional diagnostic criteria can be identified, it helps to diagnose HCC: in 40-60% of 
HCC cases a picture of mosaic tumour is seen; lesions of portal or hepatic veins, 
characterized by defects of vascular lumen filling, are seen in 33-48% of all cases; central scar 
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consisting of collagen, fibrotic and sclerotic tissue and internal fatty components are seen in 
2-21% of all cases (fig. 15).  
  
                                           (a)                                                                         (b) 
 
(c) 
Fig. 15. Hepatocellular carcinoma with portal vein invasion. (a, b) Contrast-enhanced CT 
image shows the typical enhancement pattern of hepatocellular carcinoma. Invasion of the 
right portal vein is confirmed. (arrow) (c) On the coronal CT reconstruction, the portal vein  
is filled with hypodense tumor thrombus, which demonstrates a small amount of 
enhancement. (arrow) 
The capsule, limiting all of the tumour or a part of it, is identified in 30-67% of HCC cases. 
The capsule is seen as hypodense rim in arterial phase, it enhances in late venous phase. 
Capsule is more common for the tumours with lower differentiation than those highly 
differenciated; it is also more common for medium sized (3-10 cm) tumours. Peripheral 
enhancement in solitary hepatocellular carcinoma (>3.0 cm in diameter) is also uncommon 
in images obtained by helical CT. Firstly, encapsulated carcinoma pseudocapsule usually 
shows an enhanced rim, arterioportal shunting around the lesion usually shows very dense, 
wedge shaped or triangular, peripheral enhancement in hepatic arterial phase and less 
enhancement in portal venous phase. This sort of enhancement should be differentiated 
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from other focal liver lesions, such as hepatic metastases, hepatic abscess, hepatic 
inflammatory pseudotumour and hepatic cavernous hemangioma (fig.16). 
  
                                         (a)                                                                        (b) 
 
(c) 
Fig. 16. Hepatocellular carcinoma with satellite nodule. The large tumor is defined on the 
right liver lobe and small satellite nodule in S7, with capsule retraction. (arrow) (a,b) 
Contrast enhanced CT images show the typical enhancement pattern of hepatocellular 
carcinoma. (c) Delayed phase image shows washout of contrast media. A hyperdense rim 
(white arrow) is present at the periphery of the tumor.  
Quick contrast wash out from HCC increases the specificity of CT and allows distinguishing 
HCC from hemangiomas, hypervascular dysplastic nodules, small arterial portal shunts, 
which mimics HCC because of contrast uptake in arterial phase. Small hemangiomas can 
appear with flash filling during the arterial phase and thus simulate HCC. These lesions 
always show enhancement on delayed-phase images, whereas HCC exhibits a washout of the 
contrast material, becoming either isoattenuating or hypoattenuating relative to liver tissue. 
CT has some lack of specificity in distinguishing HCC from tumours such as metastases, 
focal nodular hyperplasia, and hepatic adenomas. In general the clinical and radiographic 
setting indicates which of these is likely in a given patient, as these tumours are rare in 
cirrhotic liver and HCC is uncommon in the healthy liver. 
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The essential HCC diagnostic criteria on CT images are as follows: hypodense area on 
unenhanced CT images; homogenous or heterogeneous enhancement in arterial phase; rapid 
wash-out in venous phase. Based on these criteria CT is 84% sensitive and 93% specific. 
3.2 Intrahepatic cholangiocarcinoma  
Intrahepatic cholangiocarcinoma (I-CCC) is a malignant tumour of bile ducts’ epithelium, 
which affects minor branches of intrahepatic bile ducts. 
Usually I-CCC is a disease of young people that can be caused by primary sclerosing 
cholangitis, secondary cholangitis, congenital liver cirrhosis, Caroli disease etc. There is no  
  
                                         (a)                                                                        (b) 
 
(c) 
Fig. 17. Intrahepatic cholangiocarcinoma. (a) Unenhanced CT image shows well defined 
hyhpodense lesion with calcification. Sattelite nodule is also seen.  Atrophy of the left liver 
lobe. (b) Arterial phase CT image shows poorly enhancement of the lesion; tiny septations 
show enhancement.  (c) Portal venous phase shows increased and persistent enhancement of 
the lesion.  
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strong evidence that intrahepatic stones can or cannot cause I-CCC, however this disease 
can be caused by recurrent cholangitis that leads to mucosal hyperplasia, adenomatous 
changes or carcinoma. I-CCC represents about 15% of all primary liver tumours. By growth 
types cholangiocarcinoma is classified into mass-forming, periductal infiltrating and 
intraductal. 
On unenhanced CT images I-CCC is seen as solitary not encapsulated hypodense lesion 
with irregular margins. Hyperdense areas inside the lesion look like calcification (fig.17). 
In both arterial and portal venous phases the most important sign is the enhancement of the 
capsule limiting jagged edges of the tumour. The tumour itself enhances very slowly. This is 
why CT imaging in arterial and venous phases shows no difference. Tumour tissue 
enhances only in delayed phase. Deformation of tumour capsule can be seen in 20% of all 
cases, dilatation of intrahepatic bile ducts is seen in 20-60% of cases (fig.18). 
  
                                           (a)                                                                         (b) 
 
(c) 
Fig. 18. Mass forming intrahepatic cholangiocarcinoma. (a) the lesion enhances 
hetreogeneously in arterial phase;(b,c) persistent enhancement is seen in portal venous 
phase. (arrow) 
www.intechopen.com
 Hepatocellular Carcinoma – Clinical Research 
 
126 
Mass-forming cholangiocarcinoma is characterized by a homogeneous sclerotic mass with 
an irregular lobulated margin, typically in the absence of haemorrhage or central necrosis. 
Uptake of c/m in the late phase is closely related to the amount of interstitial space in the 
fibrous stroma. Peripheral masses are sometimes associated with capsular retraction. About 
80% of all lesions enhance in the late phase.  
Diffuse periductal thickening and increased enhancement due to tumour infiltration, with 
an abnormally dilated or irregularly narrowed duct and peripheral ductal dilatation  is 
typical for periductal infiltrative type. This is one of the least common types of 
cholangiocarcinoma. Most of hilar cholangiocarcinomas are of this type. Periductal 
cholangiocarcinoma tends to be localized to one segment or lobe and manifests with ductal 
dilatation, a finding that is indicative of biliary disease. This is a very important sign 
differentiating this type of cholangiocarcinoma from periportal lymphangitic metastasis or 
from the extrahepatic tumour. Metastases are usually localised in a few liver lobes and do 
not cause ductal dilatation (fig.19). 
  
                                         (a)                                                                        (b) 
 
(c) 
Fig. 19. Intraductal infiltrating cholangiocarcinoma. CT scan images show diffuse ductal 
dilatation in the both hepatic lobes with no visible intraductal mass.  
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On precontrast CT images intraductal cholangiocarcinomas appear as a lesion within the 
dilated bile duct that is hypo- and isodense compared to surrounding liver tissue. After 
administration of contrast media, the intraductal tumour shows enhancement. This type of 
tumour can be distinguished from HCC invading the bile duct on the basis of identification 
of the mass outside the ductal system, hypervascularity at dynamic imaging, the presence of 
a prominent fibrous capsule or pseudocapsule, and other imaging features favouring HCC. 
This type of intraductal tumour may also be confused with an intraductal mass-like stone. 
The absence of enhancement and the high attenuation on unenhanced CT images are useful 
in making the diagnosis of an intraductal mass-like stone, whereas an enhancing polypoid 
mass with asymmetric adjacent bile duct wall thickening is suggestive of an intraductal 
tumour (fig.20). 
  
                                         (a)                                                                        (b) 
Fig. 20. Intrahepatic stone disease. (a,b) Arterial and portal venous phase CT images show 
dilated intrahepatic bile ducts in the left liver lobe with hepatolithiasis (arrow).  
The diagnostic criteria of I-CCC on CT images are as follows: hypodense or isodense lesion 
on unenhanced CT images; slight peripheral enhancement in arterial phase; that emerges in 
venous phase. Based on these criteria CT imaging is 78% sensitive and 89% specific. 
3.3 Metastases 
Liver is the second most common (after lymph nodes) organ, where different malignant 
tumours metastasize. 80% patients with extrahepatic tumour are expected to have liver 
metastases. Multiple hepatic metastases are way more common (>90%) than solitary ones 
(<10%). Both liver lobes are more likely to be affected (77%) than the right one (20%) or the 
left one (31%) alone. Lesions may be infiltrative, expansive or miliary. Liver metastases may 
be hypovascular or hypervascular (fig. 21). 
Few lesions may look completely different in one patient due to variations in cellular 
differentiation, fibrosis, necrosis, haemorrhage, and blood supply. This is typical for 
metastases from renal cell carcinoma, carcinoid, choriocarcinoma and some types of lung 
cancer. Majority of authors differentiate hypervascular liver metastases from FNH and 
HCC. Primary tumours that are the most likely to metastasise to the liver are ophthalmic 
and pancreatic (70-75%), breast, gall-bladder and extrahepatic bile ducts, colon and rectal 
(about 60%), and stomach (about 50%). 
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Fig. 21. Hepatic metastases from GIST. Multiple large masses show heterogeneous 
enhancement, intralesional  irregular necrotic areas are seen.  
On contrast enhanced CT images characteristic of enhancement of liver metastases is 
determined by the primary tumor. Most liver metastases are hypovascular. This is why 
they look hypodense on CT images, especially in portal venous phase compared to 
normal liver parenchyma. Central hypodense area caused by tissue necrosis may be seen 
on CT images (fig.22). 
  
                                        (a)                                                                         (b) 
Fig. 22. Hepatic metastasis from colon carcinoma. (a) Arterial phase CT image shows a 
hypodense lesion with biliary duct dilatation in the left liver lobe (arrow). (b) Portal venous 
phase image: the lesion is hypodense to the surrounding liver parenchyma (arrow). 
Peripheral hyperdense border rim can be visualized due to peripheral afferent blood vessels 
or hyperemia of liver tissue. The borders of metastases may be sharply defined, ill-defined, 
or nodular, and their shape may be ovoid, round, or irregular. 
Hipervascular metastases (RCC, pancreatic carcinoma, sarcoma or melanoma) enhance 
more or less homogenously intensively in arterial phase. Normally arterial phase is crucial 
in evaluation of metastases as hyperenhancement is caused by hepatic artery supplying 
blood to the tumor (fig. 23).  
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                                    (a)                                                                       (b) 
 
(c) 
Fig. 23. Hepatic metastasis from renal cell carcinoma. a) Arterial phase CT image shows 
peripheral contrast enhancement, with hypodense centre of the lesion. (b) Portal venous 
phase CT image shows a slightly hyperenhancement of the lesion. (c) Delayed phase image - 
metastatic lesion is hypodense. Central part of the  lesion shows necrosis. 
However, sometimes metastases can enhance atypically. 
In Van Leeuwen study, 11% of colorectal metastases enhanced heterogeneously, and about 
60% of metastases from hypervascular tumours did not enhance at all. Metastases may 
develop calcification that is detectable by CT in the presence of mucin, necrosis, and 
phosphatase activity (fig.24). 
This is typical for metastases from mucin adenocarcinoma, such as colon, pancreatic, and 
stomach cancer. Sometimes in case of mucin producing tumour cystic metastases may be 
found in the liver. On CT images they look like foci with peripheral ring enhancement. In all 
unclear cases differentiation from common liver cysts is required (fig. 25). 
It is very important to differentiate peripheral enhancement in FLL, especially metastases, 
from nodular peripheral enhancement in first few seconds of arterial phase that gradually 
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becomes more intensive in portal venous, venous and delayed phases. This character of 
enhancement is typical for liver hemangiomas. It is a reliable sign of non-malignant lesion. 
  
                                        (a)                                                                            (b) 
Fig. 24. Metastatic melanoma. (a) Contrast-enhanced CT image during hepatic arterial phase 
shows a multiple hyperattenuating hepatic metastases. (b) On portal venous phase we see 
washout of contrast media. 
 
  
                                       (a)                                                                          (b) 
Fig. 25. Hepatic metastasis of neuroendocrine tumor. (a) On arterial CT phase, a large 
hypervascular tumor is seen as hyperattenuating mass with central necrosis. (b)  In the 
portal venous phase tumor becomes isodense to surrounding liver parenchyma; necrosis 
remains hypodense.  
Arterial-venous shunts, liver perfusion abnormalities and focal or diffuse fatty degeneration 
can also mimic metastases, so radiological differential diagnostic with these lesions is 
necessary. 
In differential diagnostics of HCC and metastases it is very important to identify the 
following CT diagnostic criteria of hypervascular areas: hypodense lesion on unenhanced 
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CT images; intensive enhancement in arterial phase and rapid wash-out (hypodense lesion) 
in venous phase. Based on these criteria CT scanning is 85% sensitive and 86 % specific. 
3.4 Rare malignant tumours 
Even though these tumours are relatively rare FLL, they also should be differentiated 
radiologically. These are fibrolamellar carcinoma (FLC), epithelioid haemangioendothelioma 
(EHE), primary liver lymphoma and biliary cystadenocarcinoma. 
3.4.1 Fibrolamellar carcinoma  
Fibrolamellar carcinoma (FLC) presents only 2% of all liver tumours and is mostly 
diagnosed in young women without chronic liver disease. According to available sources, 
FLC should be differentiated from benign FNL, such as FNH, large haemangioma, and 
sometimes – HCA. It is challenging to differentiate FLC from HCC when the lesion 
enhances heterogeneously. This is why the late phase is so important: it visualises 
hypodense homogenous FLC.  
Fibrolamellar carcinoma is another hypervascular tumour occurring in young adults and it 
usually contains a fibrotic scar. However it is not difficult to differentiate it from FNH. FLC 
is usually a large (>10-cm), heterogeneous, lobulated mass with broad central or eccentric 
scars and radiating septa. Calcifications are found in 68% of FLC, and obvious signs of 
malignancy such as lymphadenopathy (65%), metastases, and biliary and vascular invasion 
are found in the majority of cases. Calcification is typical of FLC, with a reported incidence of 
35–68%. Calcifications may be punctate, nodular, or stellate and are usually small (<5 mm), 
few (one to three in number), and almost always located near the centre of the tumour. FLC 
demonstrates a central scar in up to 20–71% of cases. It is typically large and may be broad or 
stellate, eccentric or central. Invasion of the hepatic vessels or bile ducts was also found to be 
an important differentiating feature, but it may be seen in less than 5% of cases of FLC. 
3.4.2 Epithelioid haemangioendothelioma  
Epithelioid hemanioendothelioma (EHE) is a rare and highly malignant tumour with 
vascular component that develops from epithelioid endothelium cells. On unenhanced CT 
images epithelioid hemangioendothelioma is hypodense compared to normal hepatic 
parenchyma. EHE usually localises in lateral liver parts and is formed of fibrotic 
hypovascular central nucleus and peripheral hypervascular rim that is still seen in the late 
phase. Capsular retraction is frequently present, and calcification is occasionally seen. 
3.4.3 Lymphoma 
Primary hepatic lymphoma is an exceptionally rare disease, representing less than 1.0 % of 
all extranodal lymphomas. Lymphoma of the liver is considered primary in the absence of 
extra-hepatic involvement or in cases of predominant hepatic presentation. Hepatic 
lymphoma is more commonly encountered in patients with cirrhosis, mostly secondary to 
hepatitis C, AIDS, systemic lupus erythematosus and in transplant recipients being treated 
with immunosuppressive drugs. The prognosis appears to be favourable in patients 
diagnosed and treated early, unless there is an underlying disease. In 57% of all cases 
primary liver lymphoma is solitary tumour. On CT images it is seen as hypodense 
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homogenous lesion of variable size and enhancement. Secondary lymphoma tends to 
present as multiple lesions in most cases, but can also show a single lesion or diffusely 
infiltrate the liver. CT features of hepatic lymphoma are non-specific and do not allow 
differentiation from other solitary or multicentric hepatic tumours (fig.26). 
 
Fig. 26. B cell lymphoma. Arterial phase CT image shows a large heterogeneous tumor in 
the right lobe with hypodense central necrosis.  
3.4.4 Billiary cystadenocarcinoma  
Billiary cystadenocarcinoma is a malignant tumour, developed from billiary cysadenoma 
(fig. 27). 
 
Fig. 27. Biliary cystadenoma in S1 with biliary ductal dilatation. Contrast-enhanced CT  
image shows a hypodense lesion in the  liver without contrast enhancement. A partial 
septation of the lesion is present. 
It is a large cystic tumour that is usually septated, but may be unilocular. The cystic spaces 
contain mucinous or serous fluid. On CT images both cystadenoma or cystadenocarcinoma 
are well defined cystic lesions that do not enhance. We can see an enhancement of the wall 
and septa of the tumour. Calcifications and soft tissue components are possible. 
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4. Conclusion 
Contrast enhanced CT is a powerful imaging technique for the accurate diagnostics of HCC. 
Arterial and portal venous phases are important in evaluation of FLL. Delayed phase is 
essential in differential diagnosis of benign and malignant lesions. These imging techniques 
should be optimized for the evaluation of suspected HCC. Typical CT features may help in 
differentiating HCC from other liver lesions.  
Contrast enhanced CT is important technique for the accurate diagnosis of HCC. Optimal 
scanning protocol is essential. Delayed phase should be always included in scanning 
protocol.  
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